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Abstract: 
A wide range of primary, secondary and tertiary propargylic alcohols undergo Meyer-Schuster rearrangement to give enones 
at room temperature in the presence of a gold(I) catalyst and small quantities of MeOH or PMPB(OH)2. The synthesis of the 
enone natural products Isoegomaketone and Daphenone was achieved using this reaction as the key step. The rearrangement 
of primary propargylic alcohols can readily be combined in a one-pot procedure with the addition of a nucleophile to the 
resulting terminal enone, giving -aryl, -alkoxy, -amino or -sulfido ketones. Propargylic alcohols bearing an adjacent 
electron-rich aryl group can also undergo silver-catalyzed substitution of the alcohol with oxygen, nitrogen and carbon 
nucleophiles. This latter reaction was initially observed with a batch of gold catalyst which was probably contaminated with 
small quantities of silver salt. 
Introduction 
α,β-Unsaturated carbonyl compounds are important building blocks in organic synthesis and are commonly used as 
substrates in a wide variety of transformations including Michael-additions,[1] Diels-Alder reactions,[2] cyclopropanations[3] 
and a wide variety of organocatalytic processes.[4] This diversity in application makes them common intermediates in the 
total synthesis of natural products and the synthesis of drug molecules. Traditionally α,β-unsaturated carbonyl compounds 
are synthesised via aldol condensation reactions, or via a Wittig,[5] Horner-Wadsworth-Emmons[6] or Petersen[7] olefination 
reaction. The Meyer-Schuster rearrangement[8]-[9] of a propargylic alcohol can provide a convenient alternative to these 
processes, which avoids the production of stoichiometric byproducts such as phosphorous oxides.  
The required propargylic alcohol can readily be synthesised through an alkynyl anion addition to an aldehyde or ketone, 
typically a high yielding process which is also highly effective even with sterically hindered carbonyls. This two step process 
can therefore offer a highly attractive method to synthesise α,β-unsaturated carbonyl compounds (Scheme 1). 
The classical Meyer-Schuster rearrangement involves heating the alcohol with strong acid, and is hence incompatible with 
many functional groups.[8] However, more recently a number of highly effective metal-catalyzed methods for achieving this 
reaction have been reported.[10]-[14] The emergence of Au(I) catalysis[15] in particular has revived this reaction, and conditions 
have been developed which enable the rearrangement to take place under very mild conditions. The first reports required the 
alcohol to be converted to the corresponding acetate derivative,[11] but more recently procedures have been developed for the 
direct rearrangement of the alcohols themselves.[12] We have previously reported that carrying out the Au-catalyzed 
rearrangement in a non-coordinating solvent, in the presence of one equivalent of methanol, greatly accelerates the 
reaction.[14]  
Herein we report on the full scope of this room temperature Meyer-Schuster rearrangement with regard to the rearrangement 
of secondary and tertiary propargylic alcohols, and its application to the synthesis of the natural products Isoegomaketone 
and Daphenone. We also report convenient one-pot procedures for the direct conversion of primary propargylic alcohols into 
β-arylketones, β-alkoxyketones, β-aminoketones and β-sulfidoketones via intermediate terminal enones. During the course 
of these studies it was observed that propargylic substitution reactions of electron rich propargylic alcohols took place in 
some cases. This interesting side reaction, which works with a wide range of oxygen, carbon and nitrogen nucleophiles, was 
shown to be mediated by silver salts, probably present as impurities in some batches of gold catalyst. 
Results and Discussion 
Rearrangement of Secondary Propargylic Alcohols 
In our preliminary experiments we quickly identified that the Au-catalyzed Meyer-Schuster rearrangement was more 
efficient using a cationic gold catalyst[16] in non-polar solvents in the presence of a small quantity of a protic additive (either 
a boronic acid or methanol).[14] A wide range of secondary propargylic alcohols underwent Meyer-Schuster rearrangement at 
room temperature upon treatment with 2 mol% Au(I) catalyst and 1 eq. of MeOH (Table 1) in PhMe as solvent. In nearly all 
cases the enone was obtained as the pure E isomer after purification (see Supporting Information). 
A variety of alkyl, alkenyl and aryl substituents at R1 on the alkyne were tolerated (Entries 1-7) and the reaction could be run 
on a 1 g scale without difficulty using only 1 mol% Au catalyst (Entry 1). An alkoxy group could be incorporated to give 
access to an ,-unsaturated ester (Entry 8). Compounds containing both electron rich aromatic groups (Entry 6) and 
electron deficient aromatic groups (Entry 5) at R1 rearranged smoothly, as did a substrate containing a thiophene ring (Entry 
7). The sterically congested substrate containing a tertiary butyl substituent (Entry 2) rearranged to the corresponding enone 
in very good yield, but required a prolonged reaction time of 16 hours. A substrate containing a conjugated alkene at R1 
(Entry 3) gave a lower yield, but this probably reflects the relative instability of the dienone product 2c rather than the yield 
of the reaction itself. A variety of substituents could also be incorporated at the R2 position (Entries 9-15). Benzylic alcohols 
rearrange efficiently (Entries 9-17) with substrates containing electron deficient (Entries 11-13) or moderately electron-
donating (Entry 10) substituents giving excellent yields. Whilst electron-rich alcohol 1n gave the corresponding enone 2n in 
excellent yield, dimethylaniline 1o gave only a 15% yield of the corresponding enone 2o. This may be due to the presence of 
the co-ordinating nitrogen atom which can potentially interfere with the gold catalyst (vide infra). Propargylic alcohols 
containing electron-rich heterocycles gave the corresponding enones in good yield (Entries 16-17), and there was no 
evidence for Au-catalyzed reaction of the electron-rich hetereocycle with the pendant enone in the product.[17] Further 
combinations of substituents could also be incorporated (Entries 18-22) including cyclopropanes (1r and 1v), which did not 
undergo ring-opening during the rearrangement reaction. The dienone 2v (Entry 22) can be generated in excellent yield from 
the corresponding propargylic alcohol 1v. Interestingly the initial major product observed from the rearrangement was the 
E,E isomer. However after purification the pure E,Z isomer 1v was obtained cleanly in good yield. Presumably this latter 
isomer is actually thermodynamically more stable in this case. 
Application to Natural Product Synthesis 
Isoegomaketone 6 is an essential oil component of perilla frutescens britt and has been shown to exhibit anti-inflammatory 
properties.[18]-[19] The natural product 6 was synthesised in two steps via fluoride-mediated addition[20] of commercially 
available silylacetylene 3 to aldehyde 4, followed by Meyer-Schuster rearrangement of the resulting mixture of alcohol 5a 
and its corresponding TMS ether 5b, with concomitant silyl deprotection. (Scheme 2). The natural product 6 was obtained in 
86% overall yield with high E:Z selectivity from the two-step sequence.  
We also carried out a short synthesis of Daphenone 13 (Scheme 3), a natural product isolated from daphne odora which 
showed cytotoxicity against five human tumor cell lines.[21] Sonigashira coupling of 4-iodophenol 8 with TMS-acetylene 7 
gave phenol 9[22] after desilylation. After protection of the phenol as a silyl ether, the alkyne 10 was lithiated and reacted 
with dihydrocinnamaldehyde 11 to give propargylic alcohol 12. Meyer-Schuster rearrangement of 12 proceeded cleanly 
without deprotection of the silyl ether, which was cleaved with fluoride to give the natural product 13 (58% yield over 6 
steps from 8). 
Problematic Substrates for the Meyer-Schuster Rearrangement 
As mentioned above, propargylic alcohols containing nitrogen functionality did not undergo efficient Meyer-Schuster 
rearrangement (Table 1, entry 15 and Scheme 4). Tertiary amine 14 was completely unreactive, whereas pyridine 15 gave 
the abnormal rearrangement product 16 in 10% yield. The low reactivity of these substrates is presumably a consequence of 
the ability of the basic nitrogen atom to co-ordinate to the Au-catalyst and deactivate it. Addition of 1 eq. of pyridine to 
alcohol 1f completely inhibited the Meyer-Schuster rearrangement of this otherwise reactive substrate. It should be noted 
that there are virtually no reports of the Au-catalyzed Meyer-Schuster rearrangement of nitrogen containing compounds in 
the literature.[23] 
Propargylic Substitution Reactions 
During the course of our evaluation of the substrate scope of the reaction (Table 1), we initially observed the formation of 
propargylic substitution product 17a in 54% yield when rearrangement of electron rich alcohol 1n was attempted, with 2n 
being produced as a minor product (Scheme 5). It subsequently transpired that the formation of such products was not 
reproducible, and appeared to be dependent on the batch of gold catalyst used in the reaction – with a new batch of catalyst 
the Meyer-Schuster rearrangement proceeded cleanly in good yield (Table 1, entry 14). 
We hypothesised that the propargylic substitution reaction was probably mediated by an impurity present in the original 
batch of gold catalyst.[22] The most likely candidate seemed to be AgNTf2,
[23] used during the preparation of the catalyst,[16] 
and pleasingly treatment of propargylic alcohol 1n with AgNTf2/MeOH in PhMe led to the formation of substitution product 
17a in good yield (Table 2, Entry 1). Reaction of alcohol 1n with HNTf2/MeOH in PhMe led to a complex mixture of 
products suggesting that this is not simply an acid-catalyzed process.[24]-[25]  
These reaction conditions were applied to a range of different nucleophiles to illustrate the scope of the reaction (Table 2). 
Substitution reactions with oxygen, (Entries 1-3) carbon (Entries 4-7), and nitrogen nucleophiles (Entries 8-9) were all 
possible. In the absence of an external nucleophile, dimerisation of the propargylic alcohol took place to form the 
symmetrical ether as a mixture of diastereoisomers (Entry 10). The presence of both an alkyne and an electron rich aromatic 
ring at R1 seem to be necessary for the substitution reaction to take place. Propargylic alcohols 1a, 1f and 1l did not react in 
the presence of AgNTf2 and MeOH even at 60 °C; similarly, benzhydrol (Ph2CHOH) and 1-phenylethanol were also 
unreactive. It should be noted that neither HNTf2 nor AgNTf2 were able to mediate the Meyer-Schuster rearrangement of the 
propargylic alcohols 1a, 1f and 1l, suggesting that an Au catalyst is essential for this reaction.[25] 
It is notable that the Ag-catalyzed substitution reaction must be highly efficient as it was the dominant reaction pathway in 
our original experiments, even though the quantity of Ag present as impurity in the 2 mol% Au-catalyst used must have been 
very small. We carried out an NMR experiment to determine the relative rates of the silver and gold catalyzed reactions 
(Scheme 6). Treatment of alcohol 1n with 1 mol% of each of the catalysts in the presence of 2 eq. MeOH in C6D6 gave a 
20:1 ratio of substitution product 17a to Meyer-Schuster rearrangement product 2n after 10 minutes at room temperature, 
illustrating that the substitution reaction is considerably faster than the Meyer-Schuster rearrangement. There are several 
reports in the literature of metal-catalyzed substitution reactions of alcohols[23],[26] and in the light of these results, it is 
possible that some of these processes may actually be mediated or assisted by trace quantities of Ag-salts that are present, 
particularly where Ag salts have been added as a co-catalyst.[27] However, it should be noted that Au(III)-catalyzed 
substitution reactions have been reported to work with propargylic alcohols which do not contain an electron-rich aromatic 
substitutent.[26d] 
During the course of these investigations, we also explored the rearrangement of terminal propargylic alcohols to see 
whether it was possible to obtain ,-unsaturated aldehydes via Meyer-Schuster rearrangement.[28] The initial reactions were 
carried out by treatment of alcohol 18 with the contaminated Au catalyst and gave a mixture of the desired aldehyde 19 and 
-methoxyketone 20. (Scheme 7). The latter product is presumably formed via Ag-mediated substitution of the alcohol, 
followed by Au-catalyzed hydration of the terminal alkyne.[29] Reaction of 18 with a new batch of catalyst gave -
hydroxyketone 21 as the major product, together with traces of aldehyde 19. As above (Table 2), treatment of alcohol 18 
with catalytic AgNTf2 in the presence of MeOH gave the substitution product 22 cleanly in good yield. Treatment of 22 with 
catalytic Au gave ketone 20, providing evidence that product 20 was formed in our original experiment via two separate 
steps catalyzed by the two different metals.[27] 
Tertiary Propargylic Alcohols  
Tertiary propargylic alcohols 23 can be easily prepared by addition of alkynyl anions to ketones, and provide access to 
sterically congested trisubstituted enones 24 upon Meyer-Schuster rearrangement. We were able to demonstrate the 
formation of a range of symmetrically and unsymmetrically substituted enones 24 in good to excellent yield and with high 
levels of geometric control in some cases (Table 3). Where there is a large difference in the size of the propargylic 
substituents, impressive selectivity is observed (Entry 4), and even when the groups are of similar size moderate selectivity 
is still obtained (Entry 2). In general, reactions of tertiary propargylic alcohols were found to be slower than those of 
secondary propargylic alcohols.  
The use of p-methoxyphenyl boronic acid[13]-[14],[30] 25 rather than MeOH as the reaction additive was found to give higher 
yields and higher E:Z selectivity in many cases, though longer reaction times were necessary. Extending the reaction time 
with MeOH as the additive did not increase the E:Z selectivity however. Interestingly, addition of boronic acid 25 to the 3:1 
ratio of enone 24d obtained from Au/MeOH catalyzed rearrangement, led to further isomerisation of the product to give an 
enhanced E:Z ratio (Scheme 8). This indicates that the boronic acid is involved in the isomerisation of the alkene, possibly 
via an addition process to give cyclic boronate 26. 
Primary Propargylic Alcohols 
The rearrangement of primary propargylic alcohols should provide a highly effective and mild method for accessing terminal 
enones. However, during the rearrangement of 27 in the presence of methanol as the additive, some addition of MeOH to 
enone 28a was observed to give 29 (Scheme 9).[12a] 
Pleasingly, in the presence of boronic acid 25 as an additive, clean rearrangement to the unsubstituted enone 28a was 
observed. The reaction provides a mild method for generating highly reactive terminal enones, and the crude product is clean 
enough to be used directly in further transformations. We therefore developed reaction conditions for the synthesis of a range 
of functionalised products by addition of nucleophiles to the crude enone, generated in situ from the propargylic alcohol 
(Table 4). In our preliminary report we outlined how Pd-catalyzed addition of boronic acids[31] could be used to access -aryl 
ketones 30 in moderate to good yield (Entries 1-4).[14] -Alkoxyketones 31 (Entries 5-6), -aminoketones 32 (Entries 7-12) 
and -sulfidoketones 33 (Entries 13-14) can also be readily prepared via simple one-pot procedures, by addition of the 
appropriate nucleophile directly to the reaction mixture after the Meyer-Schuster rearrangement reaction is complete. 
Conclusion 
In the presence of catalytic PPh3AuNTf2 and a protic additive such as MeOH or PMPB(OH)2, the Meyer-Schuster 
rearrangement of a wide range of propargylic alcohols occurs in generally good to excellent yield. Secondary alcohols 
rearrange with high selectivity for the E-isomer of the enone product and tertiary alcohols with moderate to high selectivity. 
This reaction was employed as a key step in the synthesis of the enone natural products Isoegomaketone and Daphenone. 
The rearrangement of primary propargylic alcohols can be combined with the addition of carbon, oxygen or nitrogen 
nucleophiles to the resulting terminal enone to give access to -substituted ketones in a one-pot procedure. During the course 
of this work, we also observed that propargylic alcohols bearing an electron-rich aryl group readily undergo substitution of 
the alcohol, with a variety of oxygen, carbon and nitrogen nucleophiles in the presence of a silver catalyst. This latter 
reaction was the dominant pathway over the desired Meyer-Schuster rearrangement with a batch of Au(I) catalyst that was 
probably contaminated with Ag(I) salts. 
Experimental Section 
All reactions were carried out under an atmosphere of air unless otherwise indicated. Tetrahydrofuran was used following purification from a zeolite drying 
apparatus. All other chemicals were used as supplied unless otherwise indicated. Column chromatography was carried out using silica gel (40-60 µm) and 
analytical thin layer chromatography was carried out using aluminium-backed plates coated with silica gel. Components were visualised using combinations of 
ultra-violet lights, iodine, ceric ammonium molybdate, phosphomolybdic acid and potassium permanganate. 1H NMR spectra were recorded at at 500 MHz or at 
600 MHz in CDCl3 using residual protic solvent CHCl3 ( = 7.26 ppm, s) as the internal standard. Chemical shifts are quoted in ppm using the following 
abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; qn, quintet; m, multiplet; br, broad or a combination of these. The coupling constants (J) are measured 
in Hertz. 13C NMR spectra were recorded at 125 MHz or at 150 MHz in CDCl3 using the central reference of CHCl3 ( = 77.0 ppm, t) as the internal standard. 
Meyer-Schuster Rearrangements to give enones 2, 16, and 24 
Compounds 2a-2b, 2d, 2f, 2r, 2u, and 24a-24f have previously been reported.[14] 
General Procedure A (Preparation of compounds 2, 6 and 13): [Ph3PAuNTf2]2PhMe (1 mol%) and methanol (1 eq.) or 4-methoxyboronic acid (0.2 eq.) were 
added to a solution of propargylic alcohol in toluene (10 mL/g) and the solution stirred magnetically at room temperature until starting material had disappeared 
(TLC). The solvent was removed in vacuo and the crude product purified by column chromatography 
(E)-1-(Cyclohex-1-en-1-yl)hex-2-en-1-one (2c):[10c] IR (film) ν = 2962, 2936, 2875, 1711 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 6.91-6.88 (m, 1H), 6.84 (dt, J 
= 15.4, 7.4 Hz, 1H), 6.63 (br d, J = 15.4 Hz, 1H), 2.30-2.24 (m, 4H), 2.20 (app q, J = 7.4 Hz, 2H), 1.68-1.56 (m 4H), 1.50 (app sx, J = 7.4 Hz, 2H), 0.94 ppm (t, 
J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 191.6, 147.0, 140.00, 139.96, 125.0, 34.8, 26.3, 23.5, 22.1, 21.7, 21.6, 13.9 ppm; Found (EI):  [M] 
178.13492, C12H18O requires 178.13522. 
(E)-1-(4-(Trifluoromethyl)phenyl)hex-2-en-1-one (2e): 1H NMR (CDCl3, 600 MHz): δ = 8.00 (d, J = 8.3 Hz, 2H), 7.73 (d, J = 8.3 Hz, 2H), 7.12-7.07 (dt, J = 
15.4, 7.2 Hz, 1H), 6.86-6.83 (br dt, J = 15.4, 1.4 Hz, 1H), 2.33 (br qd, J = 7.2, 1.5 Hz, 2H), 1.60-1.53 (app sx, J = 7.4 Hz, 2H), 0.98 ppm (t, J = 7.4 Hz, 3H); 13C 
NMR (CDCl3, 150 MHz): δ = 190.2, 151.6, 141.0, 134.0 (q, J = 32.5 Hz), 128.9, 125.9, 125.7 (q, J = 3.7 Hz), 123.9 (q, J = 274 Hz), 35.1, 21.5, 13.9 ppm; 
Found (EI):  [M] 242.09084, C13H13OF3 requires 242.09130 
(E)-1-(Thiophen-3-yl)hex-2-en-1-one (2g): IR (film) ν = 2963, 2933, 2874, 1665 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 8.05 (m, 1H), 7.59 (br d, J = 4.9 Hz, 
1H), 7.33-7.31 (m, 1H), 7.08 (dt, J = 15.5, 7.1 Hz, 1H), 6.77 (br d, J = 15.5 Hz, 1H), 2.30-2.25 (m, 2H), 1.54 (app sx, J = 7.4 Hz, 2H), 0.96 ppm (t, J = 7.4 Hz, 
3H); 13C NMR (CDCl3, 150 MHz): δ = 184.4, 149.1, 142.9, 132.1, 127.6, 126.7, 125.4, 34.9, 21.6, 13.9 ppm; Found (EI): [M] 180.06071, C10H12OS requires 
180.06034 
(E)-Ethyl 5-phenylpent-2-enoate (2h):[32] 1H NMR (CDCl3, 600 MHz): δ = 7.29 (t, J = 7.5 Hz, 2H), 7.20 (t, J = 7.5 Hz, 1H), 7.18 (d, J = 7.5 Hz, 2H), 7.00 (dt, 
J = 15.7, 6.9 Hz, 1H), 5.84 (dt, J = 15.7, 1.6 Hz, 1H), 4.18 (q. J = 7.2 Hz, 2H), 2.77 (t, J = 7.6 Hz, 2H), 2.55-2.50 (m, 2H), 1.28 ppm (t, J = 7.2 Hz, 3H); 13C 
NMR (CDCl3, 150 MHz): δ = 166.7, 148.2, 140.9, 128.6, 128.4, 126.3, 121.9, 60.3, 34.4, 34.1, 14.4 ppm; Found (EI): [M-OEt] 159.08089, C11H11O requires 
159.08044. 
(E)-1-Phenylhept-1-en-3-one (2i):[33] IR (film) ν = 2955, 2942, 2926, 2866, 1649 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.55 (d, J = 16.3 Hz, 1H), 7.56-7.53 
(m, 2H), 7.41-7.38 (m, 3H), 6.75 (d, J = 16.3 Hz, 1H), 2.64 (t, J = 7.5 Hz, 2H), 1.69-1.64 (m, 2H), 1.39 (app sx, J = 7.5 Hz, 2H), 0.94 ppm (t, J = 7.5 Hz, 3H); 
13C NMR (CDCl3, 150 MHz): δ = 200.9, 142.4, 134.7, 130.5, 129.1, 128.4, 126.4, 40.8, 26.6, 22.6, 14.1 ppm. 
(E)-1-(4-Tolyl)hept-1-en-3-one (2j):[33] IR (film) ν = 2955, 2930, 2862, 1648 cm-1; 1H NMR (CDCl3, 500 MHz): δ = 7.53 (d, J = 16.3 Hz, 1H), 7.45 (d, J = 8.0 
Hz, 2H), 7.20 (d, J = 8.0 Hz, 2H), 6.70 (d, J = 16.3 Hz, 1H), 2.65 (t, J = 7.5 Hz, 2H), 2.38 (s, 3H), 1.65 (qn, J = 7.5 Hz, 2H), 1.39 (sx, J = 7.5 Hz, 2H), 0.94 ppm 
(t, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ = 201.0, 142.5, 141.0, 131.9, 129.8, 128.4, 125.5, 40.7, 26.7, 22.6, 21.6, 14.1 ppm. 
(E)-1-(4-Fluorophenyl)hept-1-en-3-one (2k):[10c] 1H NMR (CDCl3, 500 MHz): δ = 7.53 (br dd, J = 8.6, 5.4 Hz, 2H), 7.50 (d, J = 16.2 Hz, 1H), 7.08 (t, J = 8.6 
Hz, 2H), 6.67 (d, J = 16.2 Hz, 1H), 2.65 (t, J = 7.4 Hz, 2H), 1.65 (qn, J = 7.4 Hz, 2H), 1.38 (app sx, J = 7.4 Hz, 2H), 0.94 ppm (t, J = 7.4 Hz, 3H); 13C NMR 
(CDCl3, 125 MHz): δ = 200.5, 162.2 (d, J = 250.7 Hz), 141.0, 130.9 (d, J = 3.8 Hz), 130.2 (d, J = 8.6 Hz), 126.0 (d, J = 1.9 Hz), 116.1 (d, J = 22.0 Hz), 40.9, 
26.5, 22.5, 14.0 ppm; Found (CI): [M+H] 207.11852, C13H16OF requires 207.11806. 
(E)-1-(4-(Trifluoromethyl)phenyl)hept-1-en-3-one (2l):[10c] 1H NMR (CDCl3, 500 MHz): δ = 7.63 (s, 4H), 7.56 (d, J = 16.3 Hz, 1H), 6.80 (d, J = 16.3 Hz, 1H), 
2.68 (t, J = 7.4 Hz, 2H), 1.67 (qn, J = 7.4 Hz, 2H), 1.38 (app sx, J = 7.4 Hz, 2H), 0.95 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ = 200.2, 141.3, 
138.1, 131.9 (q, J = 32.7 Hz), 128.4, 128.3, 125.6 (q, J = 3.8 Hz), 123.9 (q, J = 271.6 Hz), 41.1, 26.3, 22.5, 14.0 ppm; Found (CI): [M+H] 257.11501, C14H16OF3 
requires 257.11532. 
(E)-1-(4-Bromophenyl)hept-1-en-3-one (2m): IR (film) ν = 2964, 2951, 2930, 2868, 1685 cm-1; 1H NMR (CDCl3, 500 MHz): δ = 7.52 (d, J = 8.5 Hz, 2H), 
7.50 (d, J = 16.1 Hz, 1H), 7.40 (d, J = 8.5 Hz, 2H), 6.72 (d, J = 16.1 Hz, 1H), 2.65 (t, J = 7.4 Hz, 2H), 1.65 (app qn, J = 7.4 Hz, 2H), 1.38 (app sx, J = 7.4 Hz, 
2H), 0.94 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ = 200.4, 140.9, 133.6, 132.2, 129.7, 126.8, 124.7, 41.0, 26.5, 22.5, 14.0 ppm; Found (CI): 
[M+H] 267.03824, C13H16OBr requires 267.03845. 
(E)-1-(4-Methoxyphenyl)hept-1-en-3-one (2n):[10c] IR (film) ν = 2958, 2934, 2872, 1685 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.51 (d, J = 16.0 Hz, 1H), 7.50 
(d, J = 8.6 Hz, 2H), 6.91 (d, J = 8.6 Hz, 2H), 6.63 (d, J = 16.0 Hz, 1H), 3.84 (s, 3H), 2.64 (t, J = 7.5 Hz, 2H), 1.67 (app qn, J = 7.5 Hz, 2H), 1.38 (app sx, J = 7.5 
Hz, 2H), 0.94 ppm (t, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 200.9, 161.6, 142.2, 130.1, 127.3, 124.2, 114.5, 55.5, 40.7, 26.8, 22.6, 14.1 ppm. 
(E)-1-(4-(Dimethylamino)phenyl)hept-1-en-3-one (2o): IR (film) ν = 2956, 2931, 2871, 1646 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.50 (d, J = 16.0 Hz, 1H), 
7.45 (d, J = 8.8 Hz, 2H), 6.68 (d, J = 8.8 Hz, 2H), 6.56 (d, J = 16.0 Hz, 1H), 3.03 (s, 6H), 2.62 (t, J = 7.5 Hz, 2H), 1.65 (app qn, J = 7.5 Hz, 2H), 1.38 (app sx, J 
= 7.5 Hz, 2H), 0.94 ppm (t, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 201.1, 152.0, 143.3, 130.1, 122.3, 121.7, 112.0, 40.4, 40.3, 27.1, 22.7, 14.1 ppm; 
Found (EI):  [M] 231.16240, C15H21ON requires 231.16176. 
(E)-1-(5-Methylthiophen-2-yl)hept-1-en-3-one (2p): IR (film) ν = 2960, 2932, 2873, 1651 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.58 (d, J = 15.8 Hz, 1H), 
7.08 (br d, J = 3.6 Hz, 1H), 6.72 (br d, J = 3.6 Hz, 1H), 6.41 (dd, J = 15.8 Hz, 1H), 2.59 (t, J = 7.4 Hz, 2H), 2.50 (s, 3H), 1.63 (app qn, J = 7.4 Hz, 2H), 1.38 
(app sx, J = 7.4 Hz, 2H), 0.93 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 200.4, 144.4, 138.1, 135.4, 132.5, 126.8, 123.9, 40.9, 26.7, 22.6, 16.0, 
14.1 ppm; Found (EI): [M] 208.09115, C12H16OS requires 208.09164. 
(E)-1-(Furan-2-yl)hept-1-en-3-one (2q): IR (film) ν = 2961, 2934, 2875, 1611 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.49 (br d, J =1.5 Hz, 1H), 7.32 (d, J = 
15.8 Hz, 1H), 6.65 (d, J = 3.4 Hz, 1H), 6.64 (d, J = 15.8 Hz, 1H), 6.47 (br dd, J = 3.4, 1.5 Hz, 1H), 2.60 (t, J = 7.4 Hz, 2H), 1.67-1.61 (m, 2H), 1.36 (app sx, J = 
7.4 Hz, 2H), 0.93 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 200.4, 151.3, 144.9, 128.6, 123.5, 115.7, 112.6, 41.3, 26.6, 22.6, 14.0 ppm; Found 
(EI): [M] 178.09903, C11H14O2 requires 178.09883. 
1-(4-Methoxyphenyl)hept-2-en-1-one (2s): IR (film) ν = 2962, 2935, 1600 cm-1; Z-Enone: 1H NMR (CDCl3, 600 MHz): δ = 7.94 (d, J = 8.6 Hz, 2H), 6.90 (d, J 
= 8.6 Hz, 2H), 6.75 (dt, J = 11.6, 1.5 Hz, 1H), 6.26 (dt, J = 11.6, 7.5 Hz, 1H), 3.87 (s, 3H), 2.60 (qd, J = 7.5, 1.5 Hz, 2H), 1.45 (app qn, J = 7.5 Hz, 2H), 1.35 
(app sx, J = 7.5 Hz, 2H), 0.90 ppm (t, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 191.1, 163.3, 148.7, 131.7, 130.8, 124.5, 113.8, 55.6, 31.6, 29.7, 22.6, 
14.1 ppm; E-Enone: 1H NMR (CDCl3, 600 MHz): δ = 7.95 (d, J = 8.8 Hz, 2H), 6.75 (dt, J = 15.5, 7.0 Hz, 1H), 6.95 (d, J = 8.8 Hz, 2H), 6.89 (dt, J = 15.5, 1.5 
Hz, 1H), 3.87 (s, 3H), 2.31 (qd, J = 7.5, 1.5 Hz, 2H), 1.50 (app qn, J = 7.5 Hz, 2H), 1.38 (app sx, J = 7.5 Hz, 2H), 0.93 ppm (t, J = 7.5 Hz, 3H); 13C NMR 
(CDCl3, 150 MHz): δ = 189.3, 163.3, 149.2, 131.0, 130.9, 125.6, 113.8, 55.6, 32.7, 30.5, 22.5, 14.0 ppm; Found (CI): [M+H] 219.13812, C14H19O2 requires 
219.13850 
(E)-1-(4-Methoxyphenyl)-5-phenylpent-2-en-1-one (2t): IR (film) ν = 2965, 2938, 1618 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.91 (d, J = 8.9 Hz, 2H), 7.31 
(t, J = 7.6 Hz, 2H), 7.22 (m, 3H), 7.07 (dt, J = 15.4, 6.9 Hz, 1H), 6.94 (d, J = 8.9 Hz, 2H), 6.88 (dt, J = 15.4, 1.3 Hz, 1H), 3.05 (s, 3H), 2.85 (t, J = 7.5 Hz, 2H), 
2.64 ppm (m, 2H); 13C NMR (CDCl3, 150 MHz): δ = 189.2, 163.4, 147.5, 141.1, 131.0, 130.8, 128.63, 128.55, 126.3, 113.9, 55.6, 34.69, 34.66 ppm; Found (EI): 
[M] 266.13090, C18H18O2 requires 266.13013. 
(2E,4Z)-1-Cyclopropylocta-2,4-dien-1-one (2v): IR (film) ν = 2965, 2936, 2876, 1704 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.23-7.18 (dd, J = 15.4, 9.6 Hz, 
1H), 6.21 (d, J = 15.4 Hz, 1H), 6.21-6.15 (m, 2H), 2.18-2.14 (m, 2H), 2.14-2.10 (m, 1H), 1.50-1.42 (app sx, J = 7.4 Hz, 2H), 1.10-1.06 (m, 2H), 0.92 (t, J = 7.4 
Hz, 3H), 0.91-0.87 ppm (m, 2H); 13C NMR (CDCl3, 150 MHz): δ = 200.6, 145.6, 142.8, 129.2, 128.1, 35.3, 22.0, 19.3, 13.8, 11.1 ppm; Found (EI): [M] 
164.11993, C11H16O requires 164.11957.  
(E)-1-(Pyridin-2-yl)hept-2-en-1-one (16): IR (film) ν = 2960, 2933, 2831, 1621 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 8.71 (m, 1H), 8.12 (d, J = 7.9 Hz, 1H), 
7.85 (td, J = 7.9, 1.5 Hz, 1H), 7.58 (dt, J = 15.6, 1.2 Hz, 1H), 7.49-7.45 (m, 1H), 7.24 (dt, J = 15.6, 7.0 Hz, 1H), 2.35 (br qd, J = 7.0, 1.2 Hz, 2H), 1.55-1.48 (m, 
2H), 1.41-1.35 (m, 2H), 0.93 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 189.7, 154.3, 150.8, 148.9, 137.1, 126.9, 124.5, 123.0, 32.8, 30.4, 22.5, 
14.0 ppm; Found (CI): [M+H] 190.12364, C12H16ON requires 190.12319. 
1,3,3-Triphenylprop-2-en-1-one (24g):[34] 1H NMR (CDCl3, 600 MHz): δ = 7.91 (br d, J = 7.3 Hz, 2H), 7.49 (br t, J = 7.3 Hz, 1H), 7.41-7.36 (m, 7H), 7.29-
7.25 (m, 3H), 7.20-7.17 (m, 2H), 7.12 ppm (s, 1H); 13C NMR (CDCl3, 150 MHz): δ = 192.8, 154.9, 141.5, 139.1, 138.3, 132.8, 129.9, 129.5, 128.9, 128.7, 
128.58, 128.51, 128.49, 128.2, 124.1 ppm; Found (CI): [M+H] 283.11288, C21H16O requires 283.1174. 
Synthesis of the Natural Products Isoegomaktone (6) and Daphenone (13): 
(E)-Isoegomaketone (6):[18]-[19] Isobutraldehyde (110 mg, 1.52 mmol), (furan-3-ylethynyl)trimethylsilane (500 mg, 3.65 mmol), and tetrabutylammonium 
triphenyldifluorosilicate (8 mg, 0.15 mmol) were dissolved in dry THF (5 mL). The resultant solution was stirred for 20 min at 0 °C. The reaction was quenched 
with aq. NaHCO3 and the organic phase extracted with diethyl ether. The combined organic phases were washed with brine, dried (MgSO4) and concentrated in 
vacuo to give 5a and 5b as a mixture. 5 was submitted without further purification to the Meyer-Schuster Rearrangement reaction conditions (General Procedure 
C) to give E-Isoegomaketone in 86% yield over the two steps. IR (film) ν = 2966, 2934, 2873, 1667 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 8.04 (m, 1H), 7.45 
(app br t, J = 1.7 Hz, 1H), 7.02 (dd, J = 15.4, 6.8 Hz, 1H), 6.83 (br dd, J = 1.7, 0.8 Hz, 1H), 6.49 (dd, J = 15.4, 1.5 Hz, 1H), 2.53 (app sxd, J = 6.8, 1.3 Hz, 1H), 
1.11 ppm (d, J = 6.8 Hz, 6H); 13C NMR (CDCl3, 150 MHz): δ = 185.0, 154.7, 147.2, 144.3, 128.2, 124.1, 109.3, 31.4, 21.5 ppm; Found (EI): [M] 164.08354, 
C10H12O2 requires 164.08318. 
t-Butyl(4-ethynylphenoxy)dimethylsilane (10):[35] (4-Hydroxyphenyl)acetylene 920 (400 mg, 3.43 mmol) and imidazole (230 mg, 3.43 mmol) were dissolved 
in DMF (10 ml) and TBSCl (510 mg, 3.43 mmol) was added. The reactants were stirred at room temperature overnight and then quenched with the addition of 
water. The resultant slurry was extracted with diethyl ether, the combined organic phases were washed with brine, dried (MgSO4) and concentrated in vacuo. 
The residue was purified by flash column chromatography to give the protected acetylene 10. IR (film) ν = 2957, 2930, 2896, 2860, 2157 cm-1; 1H NMR 
(CDCl3, 600 MHz): δ = 7.38 (d, J = 8.6 Hz, 2H), 6.78 (d, J = 8.6 Hz, 2H), 2.99 (s, 1H), 0.98 (s, 9H), 0.20 ppm (s, 6H); 
13C NMR (CDCl3, 150 MHz): δ = 156.4, 
133.7, 120.3, 114.9, 83.8, 76.0, 25.7, 0.17, -4.3 ppm; Found (EI):  [M] 233.12850, C14H20OSi requires 232.12779 
1-(4-((t-Butyldimethylsilyl)oxy)phenyl)-5-phenylpent-1-yn-3-ol (12): Prepared according to general procedure SA (see Supporting Information); IR (film) ν = 
3650, 3007, 2944, 2293 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.32 (d, J = 8.6 Hz, 2H), 7.31-7.28 (m, 2H), 7.26-7.24 (m, 2H), 7.22-7.19 (m, 1H), 6.79 (d, J = 
8.6 Hz, 2H), 4.59 (br t, J = 5.5 Hz, 1H), 2.86 (t, J = 7.5 Hz, 2H), 2.14-2.08 (m, 2H), 1.96 (br s, 1H), 0.98 (s, 9H), 0.20 ppm (s, 6H); 13C NMR (CDCl3, 150 
MHz): δ = 156.2, 141.5, 133.3, 128.7, 128.6, 126.1, 120.3, 115.4, 88.6, 85.4, 62.5, 39.5, 31.6, 25.8, 18.3, -4.3 ppm; Found (EI):  [M] 366.20131, C23H30O2Si 
requires 366.20096 
Daphenone (13):[21] Prepared according to General Procedure A; IR (film) ν = 2954, 2926, 2856, 1737 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.85 (d, J = 8.8 
Hz, 2H), 7.29 (m, 2H), 7.21 (m, 3H), 7.07 (dt, J = 15.3, 6.8 Hz, 1H), 6.89 (d, J = 8.8 Hz, 2H), 6.88 (dt, J = 15.3, 1.3 Hz, 1H), 6.44 (br s, 1H), 2.84 (t, J = 7.5 Hz, 
2H), 2.64 ppm (m, 2H); 13C NMR (CDCl3, 150 MHz): δ = 189.7, 160.4, 148.1, 141.0, 131.4, 130.6, 128.6, 128.5, 126.30, 126.26, 115.5, 34.69, 34.63 ppm; 
Found (EI):  [M] 252.11537, C17H16O2 requires 252.11448. 
Silver Catalyzed Substitution of Propargylic Alcohols 
General Procedure B (Preparation of compounds 17 and 22): AgNTf2 (1 mol%) and nucleophile (2 eq.) were added to a solution of propargylic alcohol in 
toluene (10 mL/g) and the solution stirred magnetically at room temperature until the starting material has disappeared (TLC) or at 60 °C overnight. The reaction 
was quenched with aq. NaHCO3 and the organic phase extracted with diethyl ether. The combined organic phases were washed with brine, dried (MgSO4) and 
concentrated in vacuo. The residue was purified by flash column chromatography to give 17. 
1-Methoxy-4-(1-methoxyhept-2-yn-1-yl)benzene (17a):[36] 1H NMR (CDCl3, 600 MHz): δ = 7.42 (d, J = 8.6 Hz, 2H), 6.89 (d, J = 8.6 Hz, 2H), 5.02 (br t, J = 
1.9 Hz, 1H), 3.81 (s, 3H), 3.37 (s, 3H), 2.29 (td, J = 7.2, 1.9 Hz, 2H), 1.56-1.51 (m, 2H), 1.47-1.40 (m, 2H), 0.92 ppm (t, J = 7.3 Hz, 3H); 13C NMR (CDCl3, 150 
MHz): δ = 159.7, 131.5, 128.9, 113.8, 88.5, 77.8, 72.9, 55.5, 55.4, 30.9, 22.1, 18.7, 13.7 ppm; Found (EI): [M] 232.14620, C15H20O2 requires 232.14578. 
2-(3-(Cyclohex-1-en-1-yl)-1-methoxyprop-2-yn-1-yl)-5-methylthiophene (17b): IR (film) ν = 3007, 2958, 2238 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 6.94 
(d, J = 3.4 Hz, 1H), 6.60 (m, 1H), 6.19 (m, 1H), 5.37 (s, 1H), 3.39 (s, 3H), 2.46 (s, 3H), 2.19-2.14 (m, 2H), 2.12-2.08 (m, 2H), 1.66-1.61 (m, 2H), 1.61-1.55 ppm 
(m, 2H); 13C NMR (CDCl3, 150 MHz): δ = 141.1, 139.9, 136.0, 126.5, 124.6, 120.1, 89.0, 83.3, 68.8, 55.0, 29.2, 25.7, 22.3, 21.5, 15.6 ppm; Found (EI): [M] 
246.10810, C15H18OS requires 246.10729. 
1-(1-(Benzyloxy)hept-2-yn-1-yl)-4-methoxybenzene (17c): IR (film) ν = 2958, 2933, 2872, 2230 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.45 (d, J = 8.6 Hz, 
2H), 7.39-7.33 (m, 4H), 7.28 (m, 1H), 6.89 (d, J = 8.6 Hz, 2H), 5.16 (br t, J = 1.9 Hz, 1H), 4.65 (d, J =  11.7 Hz, 1H), 4.62 (d, J =  11.7 Hz, 1H), 3.81 (s, 3H), 
2.31 (td, J = 7.1, 1.9 Hz, 2H), 1.55 (app qn, J = 7.4 Hz, 2H), 1.45 (app sx, J = 7.4 Hz, 2H), 0.93 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 
159.6, 138.2, 131.6, 129.0, 128.5, 128.2, 127.7, 113.8, 88.6, 78.0, 70.4, 69.6, 55.4, 30.9, 22.1, 18.7, 13.8 ppm; Found (EI): [M] 308.17794, C21H24O2 requires 
308.17708. 
2-(1-(4-Methoxyphenyl)hept-2-yn-1-yl)furan (17d): IR (film) ν = 2957, 2930, 2871, 2265, 1607 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.32 (d, J = 8.7, 2H), 
7.30 (m, 1H), 6.86 (d, J = 8.7 Hz, 2H), 6.28 (br dd, J = 3.2, 1.9 Hz, 1H), 6.16 (br dt, J = 3.2, 0.9 Hz, 1H), 4.96 (br t, J = 2.2 Hz, 1H), 3.79 (s, 3H), 2.26 (td, J = 
7.1, 2.2 Hz, 2H), 1.52 (app qn, J = 7.4 Hz, 2H), 1.43 (app sx, J = 7.4 Hz, 2H), 0.91 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 158.8, 155.1, 
142.1, 131.8, 128.9, 114.0, 110.3, 106.1, 84.2, 78.2, 55.4, 36.6, 31.1, 22.1, 18.7, 13.8 ppm; Found (EI): [M] 268.14630, C18H20O2 requires 268.14577. 
2-(1-(4-Methoxyphenyl)hept-2-yn-1-yl)-5-methylfuran (17e): IR (film) ν = 2956, 2932, 2871, 2837, 2249, 1609 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.32 
(d, J = 8.7 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 6.02 (br d, J = 2.9 Hz, 1H), 5.86 (br dd, J = 2.9, 1.1 Hz, 1H), 4.91 (br s, 1H), 3.79 (s, 3H), 2.26 (td, J = 7.1, 2.2 Hz, 
2H), 2.23 (s, 3H), 1.53 (app qn, J = 7.4 Hz, 2H), 1.43 (app sx, J = 7.4 Hz, 2H), 0.92 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 158.7, 153.2, 
151.7, 132.1, 128.9, 113.9, 106.8, 106.2, 84.0, 78.5, 55.4, 36.6, 31.1, 22.1, 18.7, 13.77, 13.76 ppm; Found (EI): [M] 282.16170, C19H22O2 requires 282.16142. 
3-(1-(4-Methoxyphenyl)hept-2-yn-1-yl)pentane-2,4-dione (17f): IR (film) ν = 2957, 2928, 2871, 2160, 1700 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.23 (d, J 
= 8.7 Hz, 2H), 6.83 (d, J = 8.7 Hz, 2H), 4.36 (dt, J = 10.8, 2.3 Hz, 1H), 4.05 (d, J = 10.8 Hz, 1H), 3.78 (s, 3H), 2.30 (s, 3H), 2.16 (td, J = 7.1, 2.3 Hz, 2H), 1.89 
(s, 3H), 1.47-1.41 (m, 2H), 1.35 (app sx, J = 7.4 Hz, 2H), 0.88 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 202.31, 202.29, 158.9, 130.9, 129.1, 
114.2, 85.3, 79.0, 76.4, 55.4, 37.1, 31.4, 30.9, 28.6, 22.0, 18.5, 13.7 ppm; Found (EI): [M] 300.17241, C19H24O3 requires 300.17200. 
1-(Dec-1-en-5-yn-4-yl)-4-methoxybenzene (17g):[26c] IR (film) ν = 2958, 2933, 2873, 2250, 1641 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.27 (d, J = 8.8 Hz, 
2H), 6.86 (d, J = 8.8 Hz, 2H), 5.86 (m, 1H), 5.07 (m, 2H), 3.79 (s, 3H), 3.68 (m, 1H), 2.45 (app t, J = 7.0 Hz, 2H), 2.25 (td, J = 7.0, 2.3 Hz, 2H), 1.51 (m, 2H), 
1.42 (app sx, J = 7.4 Hz, 2H), 0.92 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 158.4, 136.0, 134.2, 128.5, 116.3, 113.9, 84.0, 81.5, 55.4, 43.3, 
37.6, 31.3, 22.1, 18.7, 13.8 ppm; Found (CI): [M+H] 243.17533, C17H22O requires 243.17489. 
t-Butyl (1-(4-methoxyphenyl)hept-2-yn-1-yl)carbamate (17h): IR (film) ν = 3351, 2959, 2933, 2870, 2250, 1699 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.41 
(br d, J = 8.7 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 5.57 (br s, 1H), 4.96 (br s, 1H), 3.80 (s, 3H), 2.24 (td, J = 7.1, 2.1 Hz, 2H), 1.50 (app qn, J = 7.4 Hz, 2H), 1.44 
(s, 9H), 1.40 (app sx, J = 7.4 Hz, 2H), 0.91 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 159.2, 154.9, 132.6, 128.2, 113.9, 85.3, 80.0, 78.6, 55.4, 
46.0, 30.8, 28.5, 22.1, 18.6, 13.7 ppm; Found (EI): [M] 340.1881, C19H27O3NNa requires 340.1889. 
N-(1-(4-Methoxyphenyl)hept-2-yn-1-yl)-4-methylbenzenesulfonamide (17i): IR (film) ν = 3270, 2958, 2933, 2872, 2251 cm-1; 1H NMR (CDCl3, 600 MHz): 
δ = 7.76 (br d, J = 8.1 Hz, 2H), 7.37 (d, J = 8.8 Hz, 2H), 7.28 (br d, J = 8.1 Hz, 2H), 6.82 (d, J = 8.8 Hz, 2H), 5.24 (br dt, J = 8.8, 2.1 Hz, 1H), 4.79 (br d, J = 8.8 
Hz, 1H), 3.78 (s, 3H), 2.42 (s, 3H), 1.96 (td, J = 7.0, 2.1 Hz, 2H), 1.30-1.22 (m, 4H), 0.85 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 159.6, 
143.3, 137.7, 130.4, 129.5, 128.7, 127.6, 114.0, 87.4, 76.9, 55.4, 49.1, 30.5, 22.0, 21.7, 18.3, 13.7 ppm; Found (ES): [M+Na] 394.1446, C21H25NO3SNa requires 
394.1453. 
4,4'-(Oxybis(hept-2-yne-1,1-diyl))bis(methoxybenzene) (17j): Mixture of distereoisomers A and B, crude ratio of A:B was 1.3:1; IR (film) ν = 2956, 2932, 
2871, 2238 cm-1; A: 1H NMR (CDCl3, 600 MHz): δ = 7.47 (d, J = 8.7 Hz, 4H), 6.86 (d, J = 8.7 Hz, 4H), 5.53 (br t, J = 1.9 Hz, 2H), 3.79 (s, 6H), 2.32 (td, J = 
7.2, 1.9 Hz, 4H), 1.55 (m, 4H), 1.45 (app sx, J = 7.4 Hz, 4H), 0.93 (t, J = 7.4 Hz, 6H); 13C NMR (CDCl3, 150 MHz): δ = 159.5, 131.8, 129.2, 113.7, 88.5, 78.1, 
69.2, 57.4, 30.9, 22.1, 18.7, 13.8 ppm; B: 1H NMR (CDCl3, 600 MHz): δ = 7.41 (d, J = 8.7 Hz, 4H), 6.88 (d, J = 8.7 Hz, 4H), 5.14 (br t, J = 1.9 Hz, 2H), 3.8 (s, 
6H), 2.26 (td, J = 7.2, 1.9 Hz, 4H), 1.54-1.49 (m, 4H), 1.41 (app sx, J = 7.4 Hz, 4H), 0.91 ppm (t, J = 7.4 Hz, 6H); 13C NMR (CDCl3, 150 MHz): δ = 159.7, 
131.5, 129.4, 113.9, 88.3, 78.4, 68.5, 55.4, 30.8, 22.2, 18.8, 13.8 ppm; Found (ES): [M+H] 419.2600, C28H35O3 requires 419.2586. 
Attempted Meyer-Schuster Rearrangement of Terminal Alkynes  
Reaction of 18 using contaminated gold catalyst[22] according to General Procedure A gave a 1:5 mixture of 19 and 20, respectively.  Reaction of 18 using a 
different batch of gold catalyst gave a mixture of compounds 19 and 21. 
(E)-3-(4-Methoxyphenyl)acrylaldehyde (19): 1H NMR (CDCl3, 600 MHz): δ = 9.65 (d, J = 7.6 Hz, 1H), 7.53 (d, J = 8.8 Hz, 2H), 7.43 (d, J = 15.8 Hz, 1H), 
6.95 (d, J = 8.8 Hz, 2H), 6.62 (dd, J = 15.8, 7.6 Hz, 1H), 3.86 ppm (s, 3H); 13C NMR (CDCl3, 150 MHz): δ = 193.9, 162.3, 152.9, 127.9, 126.9, 126.7, 114.7, 
55.64 ppm. 
1-Methoxy-1-(4-methoxyphenyl)propan-2-one (20):[37] Reaction of 22 according to General Procedure A with an uncontaminated batch of gold catalyst gave 
20 as the sole product. IR (film) ν = 3002, 2937, 2909, 1716 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.29 (d, J = 8.5 Hz, 2H), 6.91 (d, J = 8.5 Hz, 2H), 4.61 (s, 
1H), 3.81 (s, 3H), 3.35 (s, 3H), 2.10 ppm (s, 3H); 13C NMR (CDCl3, 150 MHz): δ = 206.8, 160.1, 130.5, 128.5, 114.4, 89.0, 57.1, 55.4, 25.4 ppm; 
1-Hydroxy-1-(4-methoxyphenyl)propan-2-one (21): General Procedure A: IR (film) ν = 3465, 3055, 2988, 1712 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.23 
(d, J = 8.9 Hz, 2H), 6.91 (d, J = 8.9 Hz, 2H), 5.05 (br d, J = 3.5 Hz, 1H), 4.24 (br d, J = 3.5 Hz, 1H), 3.81 (s, 3H), 2.07 ppm (s, 3H); 13C NMR (CDCl3, 150 
MHz): δ = 207.5, 160.0, 130.1, 128.8, 114.5, 79.7, 55.4, 25.4 ppm; Found (EI): [M] 180.07883, C10H12O3 requires 180.07810. 
1-Methoxy-4-(1-methoxyprop-2-yn-1-yl)benzene (22): Prepared according to General Procedure B; IR (film) ν = 2995, 2936, 2904, 2174 cm-1; 1H NMR 
(CDCl3, 600 MHz): δ = 7.44 (d, J = 8.7 Hz, 2H), 6.91 (d, J = 8.7 Hz, 2H), 5.04 (br d, J = 2.1 Hz, 1H), 3.81 (s, 3H), 3.42 (s, 3H), 2.65 ppm (br d, J = 2.1 Hz, 1H); 
13C NMR (CDCl3, 150 MHz): δ = 159.9, 130.3, 128.9, 114.0, 81.6, 75.7, 72.5, 55.8, 55.4 ppm; Found (EI): [M] 176.08350, C11H12O2 requires 176.08318.   
One-Pot Syntheses of β-Substituted Ketones 30-33  
Compounds 30a-d have previously been reported.[14] 
General Procedure C (Preparation of compounds 31-33): [Ph3PAuNTf2]2PhMe (1 mol%) and alcohol (2 eq.) or 4-methoxyboronic acid (0.2 eq.) were added 
to a solution of propargylic alcohol in toluene (10 mL/g) and the solution stirred magnetically at room temperature until starting material had disappeared 
(TLC). After this time nucleophile (2 eq.) was added to the solution and it was stirred overnight at room temperature. The solvent was removed in vacuo and the 
crude product purified by column chromatography to give the β-substituted ketone. 
1-(Benzyloxy)hexan-3-one (31a): IR (film) ν = 2963, 2935, 2875, 1712 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.36-7.25 (m, 5H), 4.51 (s, 2H), 3.74 (t, J = 6.3 
Hz, 2H), 2.69 (t, J = 6.3 Hz, 2H), 2.43 (t, J = 7.3 Hz, 2H), 1.59 (app sx, J = 7.4 Hz, 2H), 0.91 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 209.6, 
138.2, 128.5, 127.81, 127.77, 73.4, 65.5, 45.5, 43.0, 17.1, 13.8 ppm; Found (EI): [M+H] 207.13812, C13H19O2 requires 207.13850. 
1-Isopropoxyhexan-3-one (31b): IR (film) ν = 2966, 2935, 2875, 1710 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 3.62 (t, J = 6.5 Hz, 2H), 3.51 (septet, J = 6.1 Hz, 
2H), 2.58 (t, J = 6.5 Hz, 2H), 2.37 (t, J = 7.4 Hz, 2H), 1.60 (app sx, J = 7.4 Hz, 2H), 1.08 (d, J = 6.1 Hz, 6H), 0.86 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 
150 MHz): δ = 209.9, 71.8, 63.2, 45.4, 43.2, 22.1, 17.1, 13.8 ppm; Found (EI): [M+H] 159.13881, C9H19O2 requires 159.13850. 
1-(Diethylamino)hexan-3-one (32a): IR (film) ν = 2968, 2928, 2856, 1709 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 2.74 (t, J = 7.5 Hz, 2H), 2.55 (t, J = 7.5 Hz, 
2H), 2.50 (q, J = 7.3 Hz, 4H), 2.40 (t, J = 7.3 Hz, 2H), 1.59 (app sx, J = 7.4 Hz, 2H), 1.01 (t, J = 7.3 Hz, 6H), 0.91 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 
150 MHz): δ = 210.9, 47.4, 47.0, 45.3, 40.5, 17.3, 13.9, 11.8 ppm; Found (EI): [M] 171.16234, C10H21ON requires 171.16177. 
1-(Dibenzylamino)hexan-3-one (32b): IR (film) ν = 2961, 2932, 2874, 1708 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.33-7.22 (m, 10H), 3.55 (s, 4H), 2.76 (t, J 
= 7.2 Hz, 2H), 2.56 (t, J = 7.2 Hz, 2H), 2.23 (t, J = 7.4 Hz, 2H), 1.53 (app sx, J = 7.4 Hz, 2H), 0.85 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 
210.6, 139.5, 129.0, 128.3, 127.1, 58.4, 48.7, 44.6, 41.0, 17.2, 13.8 ppm; Found (EI): [M] 295.19352, C20H25NO requires 295.19307. 
1-Morpholinohexan-3-one (32c): IR (film) ν = 2960, 2855, 2809, 1709 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 3.68 (br t, J = 4.6 Hz, 4H), 2.67-2.55 (m, 4H), 
2.42 (br s, 4H), 2.40 (t, J = 7.4 Hz, 2H), 1.60 (app sx, J = 7.4 Hz, 2H), 0.90 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 209.9, 67.0, 53.7, 53.2, 
45.1, 40.1, 17.2, 13.8 ppm; Found (EI): [M] 186.15011, C10H20O2N requires 186.14940. 
1-(4-Methylpiperazin-1-yl)hexan-3-one (32d): IR (film) ν = 2961, 2936, 2876, 2794, 1711 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 2.65 (t, J = 7.1 Hz, 2H), 
2.58 (t, J = 7.1, 2H), 2.39 (t, J = 7.4 Hz, 2H), 2.26 (s, 3H), 2.71-2.20 (m, 8H), 1.58 (app sx, J = 7.4 Hz, 2H), 0.89 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 
MHz): δ = 210.2, 55.2, 53.1, 52.8, 46.1, 45.1, 40.4, 17.3, 13.9 ppm; Found (EI): [M] 198.17302, C11H22ON2 requires 198.17266. 
1-(1,2,3,4-Tetrahydroisoquinolin-2-yl)hexan-3-one (32e): IR (film) ν = 2960, 2931, 2874, 1709 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.13-7.07 (m, 3H), 
7.01 (m, 1H), 3.63 (br s, 2H), 2.89 (br t, J = 6.0 Hz, 2H), 2.84 (t, J = 7.3 Hz, 2H), 2.74 (t, J = 6.0 Hz, 2H), 2.71 (t, J = 7.3 Hz, 2H), 2.44 (t, J = 7.4 Hz, 2H), 1.61 
(app sx, J = 7.4 Hz, 2H), 0.91 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 210.2, 134.5, 134.2, 128.7, 126.7, 126.3, 125.8, 56.2, 52.7, 51.1, 45.2, 
40.8, 29.2, 17.3, 13.9 ppm; Found (EI): [M] 232.1707, C15H22ON requires 232.1701. 
1-(Methyl(phenyl)amino)hexan-3-one (32f): IR (film) ν = 2963, 2951, 2810, 1710 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.24 (m, 2H), 6.71 (m, 3H), 3.64 (t, 
J = 6.9 Hz, 2H), 2.92 (br s, 3H), 2.67 (t, J = 6.9 Hz, 2H), 2.38 (t, J = 7.4 Hz, 2H), 1.63-1.54 (2H, m, CH2), 0.89 ppm (t, J = 7.4 Hz, 3H); 
13C NMR (CDCl3, 150 
MHz): δ = 210.5, 129.4, 128.7, 116.7, 112.5, 47.5, 45.6, 39.4, 38.6, 17.2, 13.8 ppm; Found (EI): [M] 205.14639 C13H19ON requires 20514612. 
1-Hexylsulfanyl-hexan-3-one (33a):[38] IR (film) ν = 2958, 2926, 2857, 1710 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 2.73 (m, 2H), 2.68 (m, 2H), 2.50 (t, J = 7.5 
Hz, 2H), 2.40 (t, J = 7.5 Hz, 2H), 1.65-1.53 (m, 4H), 1.39-1.22 (m, 6H), 0.91 (t, J = 7.2 Hz, 3H), 0.88 ppm (t, J = 7.0 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ = 
209.5, 45.1, 42.9, 32.6, 31.5, 29.7, 28.7, 25.9, 22.7, 17.3, 14.2, 13.8 ppm. 
1-(Phenylthio)hexan-3-one (33b):[39] IR (film) ν = 2961, 2933, 2875, 1710 cm-1; 1H NMR (CDCl3, 600 MHz): δ = 7.35-7.32 (m, 2H), 7.31-7.27 (m, 2H), 7.21-
7.18 (m, 1H), 3.14 (t, J = 7.4 Hz, 2H), 2.72 (t, J = 7.4 Hz, 2H), 2.37 (t, J = 7.4 Hz, 2H), 1.55 (m, 2H), 0.90 ppm (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 150 
MHz): δ = 209.2, 135.9, 129.5, 129.1, 126.4, 45.1, 42.2, 27.6, 17.3, 13.8 ppm. 
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Scheme and Figure Legends 
Scheme 1. Convenient access to α,β-unsaturated carbonyl compounds. 
Scheme 2. Two-step synthesis of E-Isoegomaketone. 
Scheme 3. Synthesis of Daphenone via a Meyer-Schuster rearrangement. 
Scheme 4. Attempted Meyer-Schuster rearrangement of nitrogen-containing compounds. 
Scheme 5. Substitution of the propargylic alcohol with ‘contaminated’ Au catalyst. 
Scheme 6. Competition between the Au and Ag-catalyzed reactions of alcohol 1n. 
Scheme 7. Ag/Au-catalyzed reactions of terminal alkynes in the presence of MeOH. 
Scheme 8. Enhancement of the E:Z ratio via addition of boronic acid 25. 
Scheme 9. Meyer-Schuster rearrangement of a primary propargylic alcohols with MeOH as the 
additive. 
Table 1. Meyer-Schuster rearrangement of secondary propargylic alcohols   
 
Entry Propargylic Alcohol Enone Yield [%] 
(E:Z )[a] 
1 
 
1a 
 
2a 91 
83[b] 
(17:1) 
2 
 
1b 
 
2b 80[c] 
(14:1) 
3 
 
1c 
 
2c 43  
(7:1) 
4 
 
1d 
 
2d 99  
(8:1) 
5 
 
1e 
 
2e 97 
(18:1) 
6 
 
1f 
 
2f 99  
(6:1) 
7 
 
1g 
 
2g 88 
(11:1) 
8 
 
1h 
 
2h 91[d] 
(20:1) 
9 
 
1i 
 
2i 96 
(20:1) 
10 
 
1j 
 
2j 98 
(18:1) 
11 
 
1k 
 
2k 77 
(15:1) 
12 
 
1l 
 
2l 78 
(18:1) 
13 
 
1m 
 
2m 96 
(19:1) 
14 
 
1n 
 
2n 99  
(12:1) 
15 
 
1o 
 
2o 15 
(8:1) 
16 
 
1p 
 
2p 84  
(7:1) 
17 
 
1q 
 
2q 85  
(5:1) 
18 
 
1r 
 
2r 98 
(13:1) 
19 
 
1s 
 
2s 92 
 (5:1) 
20 
 
1t 
 
2t 93 
(24:1) 
21 
 
1u 
 
2u 87 
(10:1) 
22 
 
1v 
 
2v 84 
(3:2)[e] 
[a] E:Z ratio measured by crude 1H NMR. [b] 1 g scale with 1 mol% catalyst. [c] 16 h at room temperature. [d] EtOH was used instead of MeOH. [e] crude 
E,E:E,Z ratio, after chromatography the pure E:Z isomer was obtained. 
 
Table 2. Ag-catalyzed substitution reactions of propargylic alcohols  
R1
OH
R2 AgNTf2 (1 mol%)
Toluene, rt, 5-12h 17a-17f1n or 1w
NuH 2 eq.
R1
Nu
R2
 
Entry Propargylic 
Alcohol 
NuH Product Yield 
1 
1n MeOH 
 
17a 
76 
2 
1w 
MeOH 
 
17b 
77 
3 
1n BnOH 
 
17c 
82 
4 
1n Furan 
 
17d 
77 
5 
1n 
2-
methylfuran 
 
17e 
96 
6 
1n acac 
 
17f 
83 
7 
1n 
CH2=CHCH2
SiMe3 
 
17g 
98 
8 
1n H2NBoc 
 
17h 
59[a] 
9 
1n H2NTs 
 
17i 
74[a] 
10 
1n None 
 
17j 
80[b] 
[a] 60˚C overnight. [b] 1.3:1 mixture of diastereoisomers. 
Table 3. Meyer-Schuster rearrangement of tertiary propargylic alcohols.  
 
Entry Propargylic Alcohol Enone Yield [%] 
(E:Z )[a] 
1 
 
23a 
 
24a 75[c] 
2 
 
23b 
 
24b 67 (3.5:1)[c] 
3 
 
23c 
 
24c 78 (2:1)[c] 
83 (2.3:1)[b]  
4 
 
23d 
 
24d 74 (3:1)[c] 
77 (>30:1)[b] 
5 
 
23e 
 
24e 72 (1.3:1)[c] 
83 (2.3:1)[b] 
6 
 
23f 
 
24f 79 (1.5:1)[c] 
82 (4.7:1)[b] 
7 
 
23g 
 
24g 82[c] 
[a]crude ratio determined by 1H NMR [b] With 0.2 eq. boronic acid 25, 16 h at rt. [c] With 1 eq. MeOH, 6 h at rt. 
Table 4. Rearrangement of primary propargylic alcohols and addition of nucleophiles to the resulting terminal enones  
 
Entry[a] ‘Nucleophile’ Product[c] Yield 
1 25/cat. Pd 
 
30a 81 
2 25/cat. Pd 
 
30b 58 
3 PhB(OH)2/cat. Pd 
 
30c 45 
4 o-tolylB(OH)2/cat. Pd 
 
30d 39 
5 BnOH 
 
31a 63 
6 i-PrOH 
 
31b 76 
7 HNEt2 
 
32a 70 
8 Bn2NH 
 
32b 65 
9 Morpholine 
 
32c 83 
10 N-Methyl piperazine 
 
32d 79 
11 Tetrahydroisoquinoline 
 
32e 84 
12 PhNHMe 
 
32f 52 
13 n-hexylSH 
 
33a 41 
14 PhSH 
 
33b 46 
 
Text for ToC 
‘Enones Made Easy’ 
Primary, secondary and tertiary propargylic alcohols undergo efficient Au-catalyzed Meyer-Schuster 
rearrangement, in the presence of protic additives. The rearrangement of primary alcohols can be 
combined with the addition of nucleophiles to the resulting enone to give -substituted ketones in a 
one-pot procedure. Electron-rich propargylic alcohols undergo Ag-catalyzed substitution with a 
variety of oxygen, carbon and nitrogen nucleophiles. 
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